2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

医学 围手术期 指南 类风湿性关节炎 物理疗法 痹症科 骨科手术 抗风湿药物 内科学 关节置换术 围手术期医学 重症监护医学 抗风湿药 外科 病理
作者
Susan M. Goodman,Bryan D. Springer,Antonia F. Chen,Marshall Davis,David Fernández,Mark P. Figgie,Heather Finlayson,Michael George,Jon T. Giles,Jeremy M. Gililland,Brian A. Klatt,Ronald MacKenzie,Kaleb D. Michaud,Andy O. Miller,Linda Russell,Alexander P. Sah,Matthew P. Abdel,BEVERLY K. JOHNSON,Lisa A. Mandl,Peter Keyes Sculco
出处
期刊:Arthritis Care and Research [Wiley]
卷期号:74 (9): 1399-1408 被引量:167
标识
DOI:10.1002/acr.24893
摘要

OBJECTIVE: To develop updated guidelines for the perioperative management of disease-modifying medications for patients with rheumatic diseases, specifically those with inflammatory arthritis (IA) and those with systemic lupus erythematosus (SLE), undergoing elective total hip arthroplasty (THA) or elective total knee arthroplasty (TKA). METHODS: We convened a panel of rheumatologists, orthopedic surgeons, and infectious disease specialists, updated the systematic literature review, and included currently available medications for the clinically relevant population, intervention, comparator, and outcomes (PICO) questions. We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to rate the quality of evidence and the strength of recommendations using a group consensus process. RESULTS: This guideline updates the 2017 recommendations for perioperative use of disease-modifying antirheumatic therapy, including traditional disease-modifying antirheumatic drugs, biologic agents, targeted synthetic small-molecule drugs, and glucocorticoids used for adults with rheumatic diseases, specifically for the treatment of patients with IA, including rheumatoid arthritis and spondyloarthritis, those with juvenile idiopathic arthritis, or those with SLE who are undergoing elective THA or TKA. It updates recommendations regarding when to continue, when to withhold, and when to restart these medications and the optimal perioperative dosing of glucocorticoids. CONCLUSION: This updated guideline includes recently introduced immunosuppressive medications to help decision-making by clinicians and patients regarding perioperative disease-modifying medication management for patients with IA and SLE at the time of elective THA or TKA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
周江阔发布了新的文献求助20
1秒前
彩色的友绿完成签到,获得积分10
1秒前
wanci的应助被远方采纳,获得10
1秒前
chenyiiii完成签到,获得积分10
2秒前
2秒前
3秒前
李健的应助被pinguin采纳,获得10
3秒前
饱满的起眸完成签到,获得积分10
3秒前
yy完成签到,获得积分10
3秒前
dde发布了新的文献求助10
4秒前
搜集达人的应助被罗伯特骚塞采纳,获得10
4秒前
活泼秋玲完成签到,获得积分10
4秒前
4秒前
4秒前
CipherSage的应助被unicorn采纳,获得30
4秒前
5秒前
5秒前
5秒前
5秒前
5秒前
思源的应助被wxwx采纳,获得10
6秒前
打打的应助被chenyiiii采纳,获得10
6秒前
7秒前
聪明的怀蕊完成签到,获得积分10
7秒前
呢喃完成签到,获得积分10
7秒前
LMosn完成签到,获得积分10
7秒前
上官若男的应助被瀛洲晚风采纳,获得30
8秒前
hh完成签到,获得积分10
8秒前
9秒前
是丹丹呀发布了新的文献求助10
9秒前
null的应助被彩色的友绿采纳,获得10
9秒前
10秒前
Aboc发布了新的文献求助10
10秒前
岚珋发布了新的文献求助30
10秒前
LMosn发布了新的文献求助10
10秒前
10秒前
10秒前
uu发布了新的文献求助10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178742
求助须知:如何正确求助?哪些是违规求助? 9569473
关于积分的说明 21804902
捐赠科研通 7773828
什么是DOI,文献DOI怎么找? 3432923
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478542